Cardiovascular problems are becoming more common, which is a major driver fueling market revenue growth. Globally, cardiovascular diseases are the leading cause of death. Rheumatic heart disease is the most prevalent kind of heart disease among those under the age of 25, according to the World Health Organization (WHO). Rheumatic heart disease claims the lives of roughly 288,348 people annually, most of whom pass away in low- or middle-income nations. Moreover, 32% of all deaths worldwide in 2019 were attributable to cardiovascular diseases (CVDs), which are estimated to have killed 17.9 million individuals. Heart attack and stroke deaths accounted for 85% of these fatalities.

The report sheds light on details about every market player in the global Artificial Intelligence Enabled Cardiology Market along with its global status, product portfolio financial standing, and business expansion plan and license agreement. The key players in the market are adopting various key strategies such as mergers and acquisitions, partnerships, joint ventures, collaborations and product launches to strengthen their market position and enhance their product base.

Request a Sample Report with Table of Contents and Figures to click Here: 

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Artificial Intelligence Enabled Cardiology market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Cleerly, Inc., HeartVista Inc.,  Inc., Pie Medical Imaging B.V., Idoven, GE HealthCare Technologies Inc., Tempus Labs, Inc., Ultromics Limited, Koninklijke Philips N.V., Dyad Medical, Inc.

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: 

Emergen Research has segmented the global Artificial Intelligence Enabled Cardiology market on the basis of type, application, end-use, and region:

Type Outlook (Revenue, USD Billion; 2019-2032)
Software
Services
Application Outlook (Revenue, USD Billion; 2019-2032)
Diagnosis
Treatment
Remote Medicine
Others
Regional Outlook (Revenue, USD Billion; 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
U.A.E.
South Africa
Turkey
Rest of MEA
The various regions analyzed in the report include:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:

Analysis and estimation of the Artificial Intelligence Enabled Cardiology Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Artificial Intelligence Enabled Cardiology Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Request Customization as per your specific requirement@ 

Latest Published Reports by Emergen Research:
 
 
 
 

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: 

Direct Line: +1 (604) 757-9756

E-mail: 

Visit for More Insights: 

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market